Genomic Vision: technology agreement with ICR London
Under the terms of the partnership, Genomic will provide the academic institution with its state-of-the-art fluorescence scanner for molecular combing, FiberVisionS, as well as its advanced AI algorithm FiberSmart.
The agreement with ICR, known for its expertise in oncology drug discovery, includes a one-off upfront payment with the possibility of additional recurring revenues from the sale of consumables, the biotech company says.
Following this order, Genomic Vision shares were up 1.5% on Tuesday on the Paris Bourse.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction